![](/img/cover-not-exists.png)
First evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregation
Sokol, Juraj, Nehaj, Frantisek, Ivankova, Jela, Mokan, Michal, Mokan, MarianLanguage:
english
Journal:
Journal of Thrombosis and Thrombolysis
DOI:
10.1007/s11239-018-1709-z
Date:
July, 2018
File:
PDF, 643 KB
english, 2018